SCHEMBL22985387

SCHEMBL22985387

N#Cc1cc(C(F)(F)F)ccc1-c1ccc(-n2c3ccccc3c3cc(-c4ccccc4)ccc32)c(-c2c(C#N)cccc2-n2c3ccccc3c3cc(-c4ccccc4)ccc32)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 1/20 0.37
FEN1 P39748 1/20 0.37
XDH P47989 2/20 0.35
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
GABRA1 P14867 2/20 0.31
GABRG2 P18507 2/20 0.31
GABRB3 P28472 2/20 0.31
GABRA5 P31644 2/20 0.31
GABRA3 P34903 2/20 0.31
KIF11 P52732 1/20 0.31
FFAR2 O15552 1/20 0.31
GRIN1 Q05586 1/20 0.31
GRIN2B Q13224 1/20 0.31
PPARG P37231 2/20 0.31
PPARA Q07869 2/20 0.31
PTPN5 P54829 1/20 0.31
HRH1 P35367 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22985392 0.97 ALOX5AP (0.39) ALOX5APFEN1XDHALDH1A1MAPT
SCHEMBL22985670 0.95 ALOX5AP (0.36) ALOX5APFEN1XDHKIF11PTPN5
SCHEMBL22985545 0.95 ALOX5AP (0.38) ALOX5APFEN1XDHALDH1A1MAPT
SCHEMBL22985390 0.94 ALOX5AP (0.39) ALOX5APFEN1XDHSMN1; SMN2GABRA1
SCHEMBL22985630 0.94 ALOX5AP (0.35) ALOX5APFEN1XDHSMN1; SMN2GABRA1
SCHEMBL22985220 0.94 PTPN5 (0.36) ALOX5APFEN1XDHGABRA1GABRG2
SCHEMBL22985549 0.94 ALOX5AP (0.36) ALOX5APFEN1XDHKIF11GRIN1
SCHEMBL21399246 0.94 SMN1; SMN2 (0.34) ALDH1A1MAPTSMN1; SMN2TDP1KIF11
SCHEMBL22985623 0.93 AR (0.39) ALOX5APFEN1XDHALDH1A1SMN1; SMN2
SCHEMBL20849115 0.93 AR (0.35) ALOX5APFEN1XDHALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices CYNORA GMBH (DE) 2021-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices OCIAD1, OCIAD2, POU2F1 ALOX5AP 2567/4885FEN1 2939/4885XDH 1167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.